WHO ICTRP trial
A randomized phase II study comparing cisplatin + docetaxel with carboplatin +…
JPRN-UMIN000024816 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000024816 |
|---|---|
| Public title | A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601) |
| Scientific title | A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601) - A randomized phase II study comparing… |
| Primary sponsor | Okayama Lung Cancer Study Group (OLCSG) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | previously untreated non-small-cell lung ccancer, stage III (N2 positive) |
| Interventions | Group A: Chemoradiotherapy consiting of Cisplatin and Docetaxel before surgery. Surgical resection is performed within 4 to 8 weeks after chemoradiotherapy is completed. After that, within 4 to 8 weeks, add 2 courses of chemotherapy… |
| Registration date | Dec 21, 2016 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: